Wisconsin Society of Otolaryngology Meeting 2023
Dates and Location
October 21-22, 2023
Kalahari Resort
1305 Kalahari Drive
Wisconsin Dells, Wisconsin
Meeting Format
This activity will be held in-person at the Kalahari Resort, Wisconsin Dells, Wisconsin.
Jointly Provided by
- Wisconsin Society of Otolaryngology
- University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP)
Target Audience
This activity is intended for otolaryngologists and advanced practice providers who treat otolaryngologic conditions.
Elements of Competence
This continuing education activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of medical knowledge, patient care and procedural skills, and the interprofessional competency of roles/responsibilities.
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will be able to:
- Describe dizziness and imbalance in the elderly and how to manage appropriately
- Identify best practices to successfully provide virtual care
- Recognize Vitamin D deficiency in their patients and how to address this condition successfully
Program Dates: October 21-22, 2023
Saturday, October 21, 2023 | |
AM | |
7:00 | Registration and Breakfast |
7:30 | Welcome, Aaron Wieland, MD |
7:35 | Vestibular Loss and Cognition in Aging Adults, Yuri Agrawal, MD, MPH, FACS |
8:35 | Refining Surveillance Through Risk Stratification: Cliniopathologic Variables Associated With Time to Distant Metastases in HPV+ OPSCC, Ellie Nuttall, MD |
8:42 | Perioperative Tracheostomy Tube Management and Length of Hospital Stay, Julliette Lucas |
8:50 | Exploring [18F]PARPi as a New PET/CT Tracer for Head and Neck Cancer Imaging, Aviv Spillinger, MD |
8:58 | Adult-Onset Recurrent Meningitis Associated With Type 1 Incomplete Partition of the Cochlea: A Review of Repair Techniques, Margaret Aasen, MD |
9:10 | Comparative Analysis of a Conservative Observational Approach vs. Surgical Intervention for Pediatric Post-Tonsillectomy Hemorrhage: Implications for Patient Management, Josh Verhagen, MD |
9:18 | Neurotology, Erin Harvey, MD |
9:25 | Current State of Safe Pregnancy Policies for the Surgical Trainee, Hayley Mann, MD |
9:35 | Break |
10:00 | Hypercoagulable/Hypocoagulable Considerations, Brian Sieck, MD |
10:15 | Dietary Sodium Does Not Cause Meniere's Disease, Michael Oldenburg, MD |
10:30 | Vitamin D Deficiency in Otolaryngology Patients, Jackie Wirkus, DNP, APRN |
10:45 | Hypoglossal Nerve Stimulation in the Pediatric Down Syndrome Population, Mike Gorelik, MD |
11:00 | It Came from LaCrosse, Part 2, Ryan Manz, MD |
11:15 | PCORI Swallow Therapy Trial for Bilateral Neck Radiation Patients, Tim McCulloch, MD |
11:30 | Follow-Up Visits for Complex Head and Neck Patients, Annie Sugar, MD; Hannah Rottinghaus, MD |
11:45 | Lessons Learned from a First Year of Practice, Thomas Gessert, MD |
12:00 | Adjourn |
Sunday, October 22, 2023 | |
AM | |
7:30 | Breakfast |
8:45 | Vestibular Function and Falls Prevention, Yuri Agrawal, MD, MPH, FACS |
9:45 | Hearing Loss and Cognitive Decline, Michael Harris, MD |
10:00 | Update in Zenker's Diverticulum, Andrew Bowen, MD |
10:15 | Break |
10:30 | Facial Plastics, Ryan Puccia, MD |
10:45 | Virtual Care in Otolaryngology, Karl Doerfer, MD; Brian Sieck, MD; Hannah Rottinghaus, MD (John Rhee, MD, Moderator) |
11:45 | Adjourn |
Planning Committee
Delight Hensler
Michael Harris, MD
Nathan Schreiber, MD
Aaron Wieland, MD
Presenters
Margaret Aasen, MD
Yuri Agrawal, MD, MPH
Andrew Bowen, MD
Karl Doerfer, MD
Thomas Gessert, MD
Mike Gorelik, MD
Michael Harris, MD
Erin Harvey, MD
Julliette Lucas
Hayley Mann, MD
Ryan Manz, MD
Tim McCulloch, MD
Ellie Nuttall, MD
Michael Oldenburg, MD
Ryan Puccia, MD
John Rhee, MD
Hannah Rottinghaus, MD
Nathan Schreiber, MD
Brian Sieck, MD
Aviv Spillinger, MD
Annie Sugar, MD
Josh Verhagen, MD
Aaron Wieland, MD
Jackie Wirkus, DNP, APRN
Policy on Faculty and Sponsor Disclosure Language
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
NAME |
ROLE(S) |
FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/ UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION |
Margaret Aasen, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Yuri Agrawal, MD, MPH | Speaker | No relevant relationships with ineligible companies to disclose | No |
Andrew Bowen, MD | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
Karl Doerfer, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Thomas Gessert, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Mike Gorelik, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Michael Harris, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Erin Harvey, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Delight Hensler | Committee Member | No relevant relationships with ineligible companies to disclose | N/A |
Julliette Lucas | Speaker | No relevant relationships with ineligible companies to disclose | No |
Hayley Mann, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Ryan Manz, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Tim McCulloch, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Cathy Means | Planner | No relevant relationships with ineligible companies to disclose | N/A |
Ellie Nuttall, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Michael Oldenburg, MD | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
Ryan Puccia, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
John Rhee, MD | Moderator | No relevant relationships with ineligible companies to disclose | No |
Hannah Rottinghaus, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Nathan Schreiber, MD | Committee Member | No relevant relationships with ineligible companies to disclose | N/A |
Brian Sieck, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Aviv Spillinger, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Annie Sugar, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Josh Verhagen, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Aaron Wieland, MD | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Jackie Wirkus, DNP, APRN | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
ACCREDITATION STATEMENT | |
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Wisconsin Society of Otolaryngology. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. | |
CREDIT DESIGNATION STATEMENTS | |
American Medical Association (AMA) | The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
Continuing Education Units (CEUs) | The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .675 continuing education units (CEUs) or 6.75 hours. |
Available Credit
- 6.75 AMA PRA Category 1 Credit™
- 6.75 University of Wisconsin–Madison Continuing Education Hours
- 6.75 Approved for AMA PRA Category 1 Credit™
Questions
For questions about registration, please email help@icep.wisc.edu. For general questions about the conference, please contact Delight Hensler at hensler@surgery.wisc.edu.
Program Changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu